.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Daiichi Sankyo
Harvard Business School
Healthtrust
Moodys
Dow
UBS
Citi
Covington
US Department of Justice

Generated: June 23, 2017

DrugPatentWatch Database Preview

CETIRIZINE HYDROCHLORIDE HIVES Drug Profile

« Back to Dashboard

What is the patent landscape for Cetirizine Hydrochloride Hives, and what generic Cetirizine Hydrochloride Hives alternatives are available?

Cetirizine Hydrochloride Hives is a drug marketed by Unique Pharm Labs, Jubilant Cadista, Perrigo R And D, Dr Reddys Labs Ltd, Orchid Hlthcare, Ipca Labs Ltd, Mylan, Unichem, Sun Pharm Inds Ltd, Sun Pharm Inds Inc, Bionpharma Inc, Aurobindo Pharma Ltd, Taro, Amneal Pharms Ny, and Torrent Pharms Llc. and is included in sixteen NDAs.

The generic ingredient in CETIRIZINE HYDROCHLORIDE HIVES is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and sixty-two suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.

Summary for Tradename: CETIRIZINE HYDROCHLORIDE HIVES

Patents:0
Applicants:15
NDAs:16
Suppliers / Packagers: see list85
Bulk Api Vendors: see list108
Clinical Trials: see list2,317
Patent Applications: see list4,599
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CETIRIZINE HYDROCHLORIDE HIVES at DailyMed

Pharmacology for Tradename: CETIRIZINE HYDROCHLORIDE HIVES

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Torrent Pharms Llc
CETIRIZINE HYDROCHLORIDE HIVES RELIEF
cetirizine hydrochloride
TABLET;ORAL079191-002Apr 15, 2010OTCNoNo► Subscribe► Subscribe
Taro
CETIRIZINE HYDROCHLORIDE HIVES RELIEF
cetirizine hydrochloride
TABLET;ORAL078072-004Jul 22, 2009OTCNoNo► Subscribe► Subscribe
Amneal Pharms Ny
CETIRIZINE HYDROCHLORIDE HIVES RELIEF
cetirizine hydrochloride
TABLET;ORAL078780-003Jan 21, 2010OTCNoNo► Subscribe► Subscribe
Unique Pharm Labs
CETIRIZINE HYDROCHLORIDE HIVES
cetirizine hydrochloride
TABLET;ORAL077829-003Aug 26, 2009OTCNoNo► Subscribe► Subscribe
Sun Pharm Inds Ltd
CETIRIZINE HYDROCHLORIDE HIVES
cetirizine hydrochloride
TABLET;ORAL077498-004Dec 27, 2007OTCNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Boehringer Ingelheim
Medtronic
Express Scripts
Baxter
Harvard Business School
Colorcon
Daiichi Sankyo
Farmers Insurance
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot